Elgendy IY - Search Results

1

Cryptogenic Stroke and Patent Foramen Ovale.

Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, Tobis JM, Meier B. Mojadidi MK, et al. Among authors: elgendy iy. J Am Coll Cardiol. 2018 Mar 6;71(9):1035-1043. doi: 10.1016/j.jacc.2017.12.059. J Am Coll Cardiol. 2018. PMID: 29495983 Free article. Review.

2

Abdominal pain and swelling as an initial presentation of spinal tuberculosis.

Elgendy AY, Mahmoud A, Elgendy IY. Elgendy AY, et al. Among authors: elgendy iy. BMJ Case Rep. 2014 Feb 19;2014:bcr2013202550. doi: 10.1136/bcr-2013-202550. BMJ Case Rep. 2014. PMID: 24554681 Free PMC article.

3

Beta-blockers in the management of coronary artery disease: are we on the verge of a new paradigm shift?

Elgendy IY, Mahmoud A, Conti CR. Elgendy IY, et al. Recent Pat Cardiovasc Drug Discov. 2014;9(1):11-21. doi: 10.2174/1574890109666140901144210. Recent Pat Cardiovasc Drug Discov. 2014. PMID: 25174339 Review.

4

Simultaneous multi-vessel coronary thrombosis in patients with ST-elevation myocardial infarction: a systematic review.

Mahmoud A, Saad M, Elgendy IY. Mahmoud A, et al. Among authors: elgendy iy. Cardiovasc Revasc Med. 2015 Apr-May;16(3):163-6. doi: 10.1016/j.carrev.2015.02.009. Epub 2015 Mar 5. Cardiovasc Revasc Med. 2015. PMID: 25772369 Review.

5

Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials.

Elgendy IY, Huo T, Mahmoud A, Bavry AA. Elgendy IY, et al. Int J Cardiol. 2015;186:98-103. doi: 10.1016/j.ijcard.2015.03.163. Epub 2015 Mar 17. Int J Cardiol. 2015. PMID: 25814353 Review.

6

Meta-analysis of 12 trials evaluating the effects of statins on decreasing atrial fibrillation after coronary artery bypass grafting.

Elgendy IY, Mahmoud A, Huo T, Beaver TM, Bavry AA. Elgendy IY, et al. Am J Cardiol. 2015 Jun 1;115(11):1523-8. doi: 10.1016/j.amjcard.2015.02.053. Epub 2015 Mar 12. Am J Cardiol. 2015. PMID: 25843920

7

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

Mahmoud A, Saad M, Elgendy AY, Abuzaid A, Elgendy IY. Mahmoud A, et al. Among authors: elgendy iy, elgendy ay. Cardiovasc Ther. 2015 Aug;33(4):227-35. doi: 10.1111/1755-5922.12124. Cardiovasc Ther. 2015. PMID: 25879426 Free article. Review.

8

Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.

Bavry AA, Elgendy IY, Mahmoud A, Jadhav MP, Huo T. Bavry AA, et al. Among authors: elgendy iy. PLoS One. 2015 May 26;10(5):e0127832. doi: 10.1371/journal.pone.0127832. eCollection 2015. PLoS One. 2015. PMID: 26010682 Free PMC article.

9

Outcomes after inappropriate nuclear myocardial perfusion imaging: A meta-analysis.

Elgendy IY, Mahmoud A, Shuster JJ, Doukky R, Winchester DE. Elgendy IY, et al. J Nucl Cardiol. 2016 Aug;23(4):680-9. doi: 10.1007/s12350-015-0240-2. Epub 2015 Aug 8. J Nucl Cardiol. 2016. PMID: 26253327 Free PMC article. Review.

10

Ranolazine in Cardiac Arrhythmia.

Saad M, Mahmoud A, Elgendy IY, Richard Conti C. Saad M, et al. Among authors: elgendy iy. Clin Cardiol. 2016 Mar;39(3):170-8. doi: 10.1002/clc.22476. Epub 2015 Oct 13. Clin Cardiol. 2016. PMID: 26459200 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page